Phase 3 Respiratory syncytial virus Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
Respiratory Syncytial Virus Infections
GlaxoSmithKline750 enrolled13 locationsNCT07220109
Recruiting
Phase 3
A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
Respiratory Syncytial Virus Infection
Simcere Pharmaceutical Co., Ltd498 enrolled4 locationsNCT07402512
Recruiting
Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
Respiratory Syncytial Virus Infections
University of Alabama at Birmingham370 enrolled15 locationsNCT05026749
Recruiting
Phase 3
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company25,000 enrolled8 locationsNCT07272434
Recruiting
Phase 3
RSV Vaccine in Transplant Recipients
Immune SuppressionVaccine Response ImpairedRespiratory Syncytial Virus Infections
University Health Network, Toronto100 enrolled1 locationNCT06593210
Recruiting
Phase 3
Comparative Efficacy of Hypertonic Saline vs Adrenaline Nebulization in Acute Bronchiolitis
Acute Bronchiolitis Due to Respiratory Syncytial Virus
Combined Military Hospital, Pakistan60 enrolled1 locationNCT06267118
Recruiting
Phase 3
Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections
Respiratory Syncytial Virus Infections
Kexing Biopharm Co., Ltd.322 enrolled1 locationNCT06363370